Literature DB >> 3612202

Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve.

T Weber, S Jürgens, W Lüer.   

Abstract

Sixty-two patients with acute idiopathic peripheral facial nerve palsy (AIPFP) and 31 patients with lymphocytic meningoradiculitis (Garin-Bujadoux or Bannwarth's syndrome) are described. Results of cerebrospinal fluid (CSF) analysis, including the measurement of immunoglobulins (Ig) G, A, and M, indicate that pleocytosis and/or disturbance of the blood-CSF barrier (BCB) and/or local immunoglobulin synthesis within the central nervous system (CNS) do occur in about 25% of patients with AIPFP. The commonest finding is a slight to moderate breakdown of BCB function without evidence of intrathecal immunoglobulin synthesis. In only about 10% of patients, further support for an inflammatory process within the CNS is found by intrathecal synthesis of oligoclonal IgG and/or localized synthesis of IgG and/or IgA. The majority of cases (75%) do not show any signs of an inflammatory process within the CNS. In contrast, lymphocytic meningopolyradiculitis (LMR) has a characteristic CSF profile with early impairment of BCB permeability as well as with rapid and predominant intrathecal IgM synthesis, which helps to distinguish monosymptomatic LMR from AIPFP. By applying a sensitive enzyme-linked immunosorbent assay to identical concentrations of IgG in serum and CSF, evidence of intrathecal synthesis of virus-specific antibodies was found only in 2 of 13 patients with AIPFP. In contrast, all 4 patients with herpes zoster oticus and peripheral facial palsy (Ramsay Hunt syndrome) showed an intrathecal IgG synthesis to varicella zoster virus lasting for up to 4 months after onset of disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612202     DOI: 10.1007/bf00314286

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  57 in total

1.  Acute peripheral facial palsy. Part of a cranial polyneuropathy?

Authors:  G Djupesland; M Degré; R Stien; S Skrede
Journal:  Arch Otolaryngol       Date:  1977-11

2.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

3.  Prognosis of the Ramsay Hunt syndrome.

Authors:  K W Heathfield; A S Mee
Journal:  Br Med J       Date:  1978-02-11

4.  Bell's palsy: the steroid controversy revisited.

Authors:  L P Burgess; D W Yim; M L Lepore
Journal:  Laryngoscope       Date:  1984-11       Impact factor: 3.325

5.  Peripheral facial palsy and infections- findings and problems.

Authors:  T Mertens; J P Thomas; C Zippel; H J Eggers
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

6.  [CSF-evaluation in unilateral, bilateral and alternant facial paralysis (author's transl)].

Authors:  P Engelhardt
Journal:  Med Klin       Date:  1976-04-23

7.  Peripheral facial palsy in children. A cerebrospinal fluid study.

Authors:  P Sandstedt; D Hydén; L M Odkvist; V Kostulas
Journal:  Acta Paediatr Scand       Date:  1985-03

8.  Bell's palsy: a 5 year review of 174 consecutive cases: an attempted double blind study.

Authors:  J S Brown
Journal:  Laryngoscope       Date:  1982-12       Impact factor: 3.325

9.  Bannwarth's syndrome (lymphocytic meningoradiculitis) in Sweden.

Authors:  B Ryberg
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth).

Authors:  R Ackermann; P Hörstrup; R Schmidt
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  2 in total

1.  Chronic HIV encephalitis--II. Clinical aspects.

Authors:  S Poser; W Lüer; D Eichenlaub; H D Pohle; T Weber; S Jürgens; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1988-01-04

2.  Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study.

Authors:  Julia Zimmermann; Sarah Jesse; Jan Kassubek; Elmar Pinkhardt; Albert C Ludolph
Journal:  J Neurol       Date:  2019-06-27       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.